Smith, Moore & Co. Iridex Corp Call Options Transaction History
Smith, Moore & Co.
- $1.1 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IRIX
# of Institutions
22Shares Held
2.68MCall Options Held
36.1KPut Options Held
0-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX1MShares$1.05 Million1.5% of portfolio
-
Vanguard Group Inc Valley Forge, PA586KShares$615,1030.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny379KShares$397,6980.0% of portfolio
-
Amh Equity LTD184KShares$193,4410.3% of portfolio
-
Geode Capital Management, LLC Boston, MA132KShares$138,3550.0% of portfolio
About IRIDEX CORP
- Ticker IRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 15,985,600
- Market Cap $16.8M
- Description
- IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser photocoagulation s...